Overview of microbicides for the prevention of human immunodeficiency virus.
about
A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection.Formulation and characterization of polymeric films containing combinations of antiretrovirals (ARVs) for HIV preventionGene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates.Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotideDevelopment and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxis.Evaluation of the lymphocyte trafficking drug FTY720 in vaginal tissuesTopical gel formulation of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 confers protection against HIV-1 vaginal challenge in a humanized mouse model.Rice endosperm is cost-effective for the production of recombinant griffithsin with potent activity against HIV.In vivo anti-herpes simplex virus activity of a sulfated derivative of Agaricus brasiliensis mycelial polysaccharide.Triple combination of carbosilane dendrimers, tenofovir and maraviroc as potential microbicide to prevent HIV-1 sexual transmission.Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?Biodistribution and pharmacokinetics of dapivirine-loaded nanoparticles after vaginal delivery in mice.
P2860
Q30431343-8E5DF2E2-4ED4-4F11-B4ED-11D199B04E98Q34495644-CBEBEFE5-A592-4FE4-8339-183CBA53CD79Q35002085-85262513-0B3A-41EB-A265-842B2F563716Q35656128-7645E599-2B30-4626-9A3D-038C2FDFA59EQ36083853-7FCCF5B6-1004-4E20-9A2A-1F011E36F1D8Q36442232-FF1BF2F7-4368-417E-86CF-0EA17DC8B669Q36674475-5B459A18-CFF6-4E78-B049-500708F04127Q36840299-B08E3385-08E8-475C-9BAC-03FA29BE00B6Q36896705-92B48D6C-9752-42D1-A2AD-C0B0A6FE0CAAQ37026684-905B74AB-5533-43E7-9C4C-F09D8C59DF7AQ41339468-03FA4BFF-2180-473A-BE1C-D9F2A6B5B8A0Q41922735-A428D53D-481C-4D54-8747-66062F0C6DECQ51166879-B187A8AE-6465-4573-8B72-3547C5FA67AD
P2860
Overview of microbicides for the prevention of human immunodeficiency virus.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Overview of microbicides for the prevention of human immunodeficiency virus.
@ast
Overview of microbicides for the prevention of human immunodeficiency virus.
@en
type
label
Overview of microbicides for the prevention of human immunodeficiency virus.
@ast
Overview of microbicides for the prevention of human immunodeficiency virus.
@en
prefLabel
Overview of microbicides for the prevention of human immunodeficiency virus.
@ast
Overview of microbicides for the prevention of human immunodeficiency virus.
@en
P2860
P1476
Overview of microbicides for the prevention of human immunodeficiency virus.
@en
P2860
P304
P356
10.1016/J.BPOBGYN.2012.01.010
P577
2012-03-02T00:00:00Z